Position in MAZE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$133,502,906
-$44,740 QoQ
Shares Held
4,473,958
0.0% QoQ
Ownership
8.05%
of shares outstanding
% of Portfolio
40.12%
of 13F equity value
Holder Rank
#2
of 161 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MAZE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TRV GP IV, LLC holds $332,772,089 across 2 Biotechnology names. MAZE ranks #2 (40.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TNGX |
Tango Therapeutics, Inc.
|
6,374,574 | $199,269,183 | |
| 2 | MAZE |
Maze Therapeutics, Inc.
This page
|
4,473,958 | $133,502,906 |
All Filings in MAZE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $133,502,906 | 4,473,958 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $133,547,646 | 4,473,958 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $185,356,079 | 4,473,958 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $157,497,730 | 6,073,958 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $74,527,464 | 6,073,958 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $66,874,277 | 6,073,958 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||